Target Price | €28.56 |
Price | €25.54 |
Potential | 11.85% |
Number of Estimates | 26 |
26 Analysts have issued a price target Bayer 2026 . The average Bayer target price is €28.56. This is 11.85% higher than the current stock price. The highest price target is €37.80 48.03% , the lowest is €22.22 12.98% . | |
A rating was issued by 29 analysts: 10 Analysts recommend Bayer to buy, 18 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2026 of 11.85% . Most analysts recommend the Bayer stock at Hold. |
25 Analysts have issued a sales forecast Bayer 2025 . The average Bayer sales estimate is €47.2b . This is 1.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €49.2b 5.72% , the lowest is €44.3b 4.83% .
This results in the following potential growth metrics:
2024 | €46.6b | 2.16% |
---|---|---|
2025 | €47.2b | 1.28% |
2026 | €47.9b | 1.53% |
2027 | €48.8b | 1.79% |
2028 | €48.9b | 0.33% |
2029 | €49.8b | 1.83% |
2030 | €50.6b | 1.47% |
2031 | €49.4b | 2.42% |
2032 | €50.0b | 1.37% |
23 Analysts have issued an Bayer EBITDA forecast 2025. The average Bayer EBITDA estimate is €9.5b . This is 18.50% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €11.6b 44.37% , the lowest is €7.9b 1.39% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €12.8b | 30.71% |
---|---|---|
2025 | €9.5b | 25.77% |
2026 | €9.9b | 4.46% |
2027 | €10.3b | 4.30% |
2028 | €9.8b | 5.29% |
2029 | €9.6b | 1.77% |
2024 | 27.42% | 29.18% |
---|---|---|
2025 | 20.10% | 26.69% |
2026 | 20.67% | 2.84% |
2027 | 21.18% | 2.47% |
2028 | 20.00% | 5.57% |
2029 | 19.29% | 3.55% |
24 Bayer Analysts have issued a net profit forecast 2025. The average Bayer net profit estimate is €4.5b . This is 239.33% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €5.0b 253.16% , the lowest is €3.8b 217.79% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-2.6b | 13.23% |
---|---|---|
2025 | €4.5b | 277.60% |
2026 | €4.8b | 6.97% |
2027 | €5.2b | 7.04% |
2028 | €5.4b | 4.72% |
2029 | €5.5b | 1.17% |
2030 | €5.5b | 0.58% |
2031 | €4.6b | 15.57% |
2032 | €4.8b | 3.55% |
2024 | -5.48% | 11.31% |
---|---|---|
2025 | 9.60% | 275.32% |
2026 | 10.12% | 5.42% |
2027 | 10.64% | 5.14% |
2028 | 11.10% | 4.32% |
2029 | 11.03% | 0.63% |
2030 | 10.81% | 1.99% |
2031 | 9.35% | 13.51% |
2032 | 9.55% | 2.14% |
24 Analysts have issued a Bayer forecast for earnings per share. The average Bayer EPS is €4.61 . This is 239.27% higher than earnings per share in the financial year 2024. The highest EPS forecast is €5.07 253.17% , the lowest is €3.90 217.82% .
This results in the following potential growth metrics and future valuations:
2024 | €-2.60 | 13.04% |
---|---|---|
2025 | €4.61 | 277.31% |
2026 | €4.93 | 6.94% |
2027 | €5.28 | 7.10% |
2028 | €5.53 | 4.73% |
2029 | €5.60 | 1.27% |
2030 | €5.56 | 0.71% |
2031 | €4.70 | 15.47% |
2032 | €4.86 | 3.40% |
Current | -8.15 | 0.64% |
---|---|---|
2025 | 5.85 | 171.78% |
2026 | 5.47 | 6.50% |
2027 | 5.11 | 6.58% |
2028 | 4.88 | 4.50% |
2029 | 4.82 | 1.23% |
2030 | 4.85 | 0.62% |
2031 | 5.74 | 18.35% |
2032 | 5.55 | 3.31% |
Based on analysts' sales estimates for 2025, the Bayer stock is valued at an EV/Sales of 1.27 and an P/S ratio of 0.55 .
This results in the following potential growth metrics and future valuations:
Current | 1.28 | 4.48% |
---|---|---|
2025 | 1.27 | 1.00% |
2026 | 1.25 | 1.51% |
2027 | 1.23 | 1.75% |
2028 | 1.22 | 0.33% |
2029 | 1.20 | 1.80% |
2030 | 1.18 | 1.44% |
2031 | 1.21 | 2.47% |
2032 | 1.20 | 1.34% |
Current | 0.55 | 2.02% |
---|---|---|
2025 | 0.55 | 1.34% |
2026 | 0.54 | 1.50% |
2027 | 0.53 | 1.76% |
2028 | 0.53 | 0.32% |
2029 | 0.52 | 1.80% |
2030 | 0.51 | 1.45% |
2031 | 0.52 | 2.49% |
2032 | 0.52 | 1.36% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Hold
➜
Hold
|
Unchanged | Apr 06 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Mar 31 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
HSBC |
Hold
➜
Hold
|
Unchanged | Mar 23 2025 |
MWB RESEARCH AG |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Apr 06 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Mar 31 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
HSBC:
Hold
➜
Hold
|
Mar 23 2025 |
Unchanged
MWB RESEARCH AG:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.